All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. After an average of 34.7 months, they all remained cancer-free.

In what can be termed a never-seen-before medical miracle, a small group of people with colorectal cancer achieved 100% ...

focuses on the transcriptome – a collection of all the mRNAs expressed in a cell – and was trained on publicly available data taken from large-scale studies that screened drugs against cancer ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

A clinical trial at Memorial Sloan Kettering Cancer Center has achieved groundbreaking results in treating rectal cancer ...

Sometimes you may receive a combination of therapies, or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted ...

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for six months. The trial conducted at Memorial Sloan Kettering Cancer Center ...

ArriVent BioPharma has acquired exclusive rights to an experimental treatment ... up front for rights to the potential cancer therapy, an antibody drug conjugate called MRG007, outside of Greater ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...